Cytokinetics is on track to complete its New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) in the third quarter of 2024. This timeline is ahead of many investors ...

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to ...

CK-4015089 is under clinical development by Cytokinetics and currently in Phase I for Muscular Dystrophy. According to GlobalData, Phase I drugs for Muscular Dystrophy does not have sufficient ...

New Orleans Saints interim coach Darren Rizzi wore a New Orleans-themed sweater with a heart on it in the first game since suspected terrorist attack on Bourbon Street. The logo on Rizzi's sweater ...

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate of ...

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of ...

How many Broadway shows has Darren Criss been in? Darren Criss has appeared on Broadway in 4 shows. How many West End shows has Darren Criss been in? Darren Criss has not appeared in the West End.

Cytokinetics has a twelve month low of $45.66 and a twelve month high of $110.25. The company has a quick ratio of 9.28, a current ratio of 9.28 and a debt-to-equity ratio of 5.93.

Cytokinetics, Incorporated announced the granting of stock options and restricted stock units (RSUs) to nine new employees on December 31, 2024, as part of their employment inducement. The company ...